Multistability in platelets and their response to gold nanoparticles

Abstract The nanoparticle (NP) response of platelets is shown to be critically dependent on extent of preactivation of platelets by an agonist like ADP. A transition from de-aggregatory to aggregatory state is triggered in the presence of gold NPs (AuNP) only in such critical conditions. Adhered and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanomedicine 2011-08, Vol.7 (4), p.376-384
Hauptverfasser: Deb, Suryyani, MSc, Patra, Hirak K., MSc, Lahiri, Prabir, PhD, Dasgupta, Anjan Kr., PhD, Chakrabarti, Kuntal, PhD, Chaudhuri, Utpal, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 384
container_issue 4
container_start_page 376
container_title Nanomedicine
container_volume 7
creator Deb, Suryyani, MSc
Patra, Hirak K., MSc
Lahiri, Prabir, PhD
Dasgupta, Anjan Kr., PhD
Chakrabarti, Kuntal, PhD
Chaudhuri, Utpal, MD
description Abstract The nanoparticle (NP) response of platelets is shown to be critically dependent on extent of preactivation of platelets by an agonist like ADP. A transition from de-aggregatory to aggregatory state is triggered in the presence of gold NPs (AuNP) only in such critical conditions. Adhered and suspended platelets respond differentially to NPs. Preactivation in the adhered state induced by shear force explains such observation. The NP effect is associated with enhanced release reaction, tyrosine phosphorylation and CD62P expression level. Unlike cancer cells, whose response is maximal when NP size is optimal (within the range 50 - 70 nm), the platelet response monotonically increases with reduction of the AuNP size. The uptake study, using quenching of quinacrine hydrochloride fluorescence by AuNP, indicates that accumulation 18 nm AuNP is several-fold higher than the 68 nm AuNP. It is further shown that AuNP response can provide a simple measure for thrombotic risk associated with nano-drugs. From the Clinical Editor Platelet aggregation can be triggered in the presence of gold nanoparticles (AuNP). Platelet response monotonically increases with reduction of the AuNP size. AuNP response can provide a simple measure for thrombotic risk associated with nano-drugs.
doi_str_mv 10.1016/j.nano.2011.01.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_888112229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1549963411000116</els_id><sourcerecordid>888112229</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-7be4bb662c49da1b0f7e4419f58a5e1ae44c51e09f24648dddf4ff7bb8147ce13</originalsourceid><addsrcrecordid>eNp9UU1rHDEMNaElSdP-gRzK3HrareTxzgeEQEmTtpDSQ9Kz8dia1FuvPbU9hf339bBpDjkEBJLgvSfeE2PnCGsEbD5u1175sOaAuIZS0B6xU9yIftU3gr96mmtxwt6ktAWoW4D-mJ1wrBF4056yz99nl23KarDO5n1lfTU5lclRTpXypsq_yMYqUpqCT1TlUD0EZ6rl8qRittpRestej8olevfYz9jPm-v7q6-r2x9fvl19ul1pIXhetQOJYWgarkVvFA4wtiQE9uOmUxtCVRa9QYJ-5KIRnTFmFOPYDkOHotWE9Rn7cNCdYvgzU8pyZ5Mm55SnMCfZdR0i57wvSH5A6hhSijTKKdqdinuJIJfw5FYuFuQSnoRS0BbS-0f5ediReaL8T6sALg4AKib_WooyaUtek7GRdJYm2Jf1L5_RtbPeauV-057SNszRl_gkysQlyLvlfcv3EAGKTFP_AyvVlgo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>888112229</pqid></control><display><type>article</type><title>Multistability in platelets and their response to gold nanoparticles</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Deb, Suryyani, MSc ; Patra, Hirak K., MSc ; Lahiri, Prabir, PhD ; Dasgupta, Anjan Kr., PhD ; Chakrabarti, Kuntal, PhD ; Chaudhuri, Utpal, MD</creator><creatorcontrib>Deb, Suryyani, MSc ; Patra, Hirak K., MSc ; Lahiri, Prabir, PhD ; Dasgupta, Anjan Kr., PhD ; Chakrabarti, Kuntal, PhD ; Chaudhuri, Utpal, MD</creatorcontrib><description>Abstract The nanoparticle (NP) response of platelets is shown to be critically dependent on extent of preactivation of platelets by an agonist like ADP. A transition from de-aggregatory to aggregatory state is triggered in the presence of gold NPs (AuNP) only in such critical conditions. Adhered and suspended platelets respond differentially to NPs. Preactivation in the adhered state induced by shear force explains such observation. The NP effect is associated with enhanced release reaction, tyrosine phosphorylation and CD62P expression level. Unlike cancer cells, whose response is maximal when NP size is optimal (within the range 50 - 70 nm), the platelet response monotonically increases with reduction of the AuNP size. The uptake study, using quenching of quinacrine hydrochloride fluorescence by AuNP, indicates that accumulation 18 nm AuNP is several-fold higher than the 68 nm AuNP. It is further shown that AuNP response can provide a simple measure for thrombotic risk associated with nano-drugs. From the Clinical Editor Platelet aggregation can be triggered in the presence of gold nanoparticles (AuNP). Platelet response monotonically increases with reduction of the AuNP size. AuNP response can provide a simple measure for thrombotic risk associated with nano-drugs.</description><identifier>ISSN: 1549-9634</identifier><identifier>EISSN: 1549-9642</identifier><identifier>DOI: 10.1016/j.nano.2011.01.007</identifier><identifier>PMID: 21310267</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Activation ; Adenosine Triphosphate - metabolism ; Adhesion ; Blood Platelets - drug effects ; Blood Platelets - metabolism ; Blood Platelets - ultrastructure ; Gold - chemistry ; Gold nanoparticle ; Granule release ; Humans ; Internal Medicine ; Metal Nanoparticles - administration &amp; dosage ; Metal Nanoparticles - chemistry ; Microscopy, Electron, Scanning ; Multi-stability ; Nanosafety measure ; Phosphorylation - drug effects ; Platelet Aggregation - drug effects ; Thrombotic risk ; Tyrosine - metabolism</subject><ispartof>Nanomedicine, 2011-08, Vol.7 (4), p.376-384</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-7be4bb662c49da1b0f7e4419f58a5e1ae44c51e09f24648dddf4ff7bb8147ce13</citedby><cites>FETCH-LOGICAL-c442t-7be4bb662c49da1b0f7e4419f58a5e1ae44c51e09f24648dddf4ff7bb8147ce13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1549963411000116$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21310267$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deb, Suryyani, MSc</creatorcontrib><creatorcontrib>Patra, Hirak K., MSc</creatorcontrib><creatorcontrib>Lahiri, Prabir, PhD</creatorcontrib><creatorcontrib>Dasgupta, Anjan Kr., PhD</creatorcontrib><creatorcontrib>Chakrabarti, Kuntal, PhD</creatorcontrib><creatorcontrib>Chaudhuri, Utpal, MD</creatorcontrib><title>Multistability in platelets and their response to gold nanoparticles</title><title>Nanomedicine</title><addtitle>Nanomedicine</addtitle><description>Abstract The nanoparticle (NP) response of platelets is shown to be critically dependent on extent of preactivation of platelets by an agonist like ADP. A transition from de-aggregatory to aggregatory state is triggered in the presence of gold NPs (AuNP) only in such critical conditions. Adhered and suspended platelets respond differentially to NPs. Preactivation in the adhered state induced by shear force explains such observation. The NP effect is associated with enhanced release reaction, tyrosine phosphorylation and CD62P expression level. Unlike cancer cells, whose response is maximal when NP size is optimal (within the range 50 - 70 nm), the platelet response monotonically increases with reduction of the AuNP size. The uptake study, using quenching of quinacrine hydrochloride fluorescence by AuNP, indicates that accumulation 18 nm AuNP is several-fold higher than the 68 nm AuNP. It is further shown that AuNP response can provide a simple measure for thrombotic risk associated with nano-drugs. From the Clinical Editor Platelet aggregation can be triggered in the presence of gold nanoparticles (AuNP). Platelet response monotonically increases with reduction of the AuNP size. AuNP response can provide a simple measure for thrombotic risk associated with nano-drugs.</description><subject>Activation</subject><subject>Adenosine Triphosphate - metabolism</subject><subject>Adhesion</subject><subject>Blood Platelets - drug effects</subject><subject>Blood Platelets - metabolism</subject><subject>Blood Platelets - ultrastructure</subject><subject>Gold - chemistry</subject><subject>Gold nanoparticle</subject><subject>Granule release</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Metal Nanoparticles - administration &amp; dosage</subject><subject>Metal Nanoparticles - chemistry</subject><subject>Microscopy, Electron, Scanning</subject><subject>Multi-stability</subject><subject>Nanosafety measure</subject><subject>Phosphorylation - drug effects</subject><subject>Platelet Aggregation - drug effects</subject><subject>Thrombotic risk</subject><subject>Tyrosine - metabolism</subject><issn>1549-9634</issn><issn>1549-9642</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU1rHDEMNaElSdP-gRzK3HrareTxzgeEQEmTtpDSQ9Kz8dia1FuvPbU9hf339bBpDjkEBJLgvSfeE2PnCGsEbD5u1175sOaAuIZS0B6xU9yIftU3gr96mmtxwt6ktAWoW4D-mJ1wrBF4056yz99nl23KarDO5n1lfTU5lclRTpXypsq_yMYqUpqCT1TlUD0EZ6rl8qRittpRestej8olevfYz9jPm-v7q6-r2x9fvl19ul1pIXhetQOJYWgarkVvFA4wtiQE9uOmUxtCVRa9QYJ-5KIRnTFmFOPYDkOHotWE9Rn7cNCdYvgzU8pyZ5Mm55SnMCfZdR0i57wvSH5A6hhSijTKKdqdinuJIJfw5FYuFuQSnoRS0BbS-0f5ediReaL8T6sALg4AKib_WooyaUtek7GRdJYm2Jf1L5_RtbPeauV-057SNszRl_gkysQlyLvlfcv3EAGKTFP_AyvVlgo</recordid><startdate>20110801</startdate><enddate>20110801</enddate><creator>Deb, Suryyani, MSc</creator><creator>Patra, Hirak K., MSc</creator><creator>Lahiri, Prabir, PhD</creator><creator>Dasgupta, Anjan Kr., PhD</creator><creator>Chakrabarti, Kuntal, PhD</creator><creator>Chaudhuri, Utpal, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20110801</creationdate><title>Multistability in platelets and their response to gold nanoparticles</title><author>Deb, Suryyani, MSc ; Patra, Hirak K., MSc ; Lahiri, Prabir, PhD ; Dasgupta, Anjan Kr., PhD ; Chakrabarti, Kuntal, PhD ; Chaudhuri, Utpal, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-7be4bb662c49da1b0f7e4419f58a5e1ae44c51e09f24648dddf4ff7bb8147ce13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Activation</topic><topic>Adenosine Triphosphate - metabolism</topic><topic>Adhesion</topic><topic>Blood Platelets - drug effects</topic><topic>Blood Platelets - metabolism</topic><topic>Blood Platelets - ultrastructure</topic><topic>Gold - chemistry</topic><topic>Gold nanoparticle</topic><topic>Granule release</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Metal Nanoparticles - administration &amp; dosage</topic><topic>Metal Nanoparticles - chemistry</topic><topic>Microscopy, Electron, Scanning</topic><topic>Multi-stability</topic><topic>Nanosafety measure</topic><topic>Phosphorylation - drug effects</topic><topic>Platelet Aggregation - drug effects</topic><topic>Thrombotic risk</topic><topic>Tyrosine - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deb, Suryyani, MSc</creatorcontrib><creatorcontrib>Patra, Hirak K., MSc</creatorcontrib><creatorcontrib>Lahiri, Prabir, PhD</creatorcontrib><creatorcontrib>Dasgupta, Anjan Kr., PhD</creatorcontrib><creatorcontrib>Chakrabarti, Kuntal, PhD</creatorcontrib><creatorcontrib>Chaudhuri, Utpal, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Nanomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deb, Suryyani, MSc</au><au>Patra, Hirak K., MSc</au><au>Lahiri, Prabir, PhD</au><au>Dasgupta, Anjan Kr., PhD</au><au>Chakrabarti, Kuntal, PhD</au><au>Chaudhuri, Utpal, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multistability in platelets and their response to gold nanoparticles</atitle><jtitle>Nanomedicine</jtitle><addtitle>Nanomedicine</addtitle><date>2011-08-01</date><risdate>2011</risdate><volume>7</volume><issue>4</issue><spage>376</spage><epage>384</epage><pages>376-384</pages><issn>1549-9634</issn><eissn>1549-9642</eissn><abstract>Abstract The nanoparticle (NP) response of platelets is shown to be critically dependent on extent of preactivation of platelets by an agonist like ADP. A transition from de-aggregatory to aggregatory state is triggered in the presence of gold NPs (AuNP) only in such critical conditions. Adhered and suspended platelets respond differentially to NPs. Preactivation in the adhered state induced by shear force explains such observation. The NP effect is associated with enhanced release reaction, tyrosine phosphorylation and CD62P expression level. Unlike cancer cells, whose response is maximal when NP size is optimal (within the range 50 - 70 nm), the platelet response monotonically increases with reduction of the AuNP size. The uptake study, using quenching of quinacrine hydrochloride fluorescence by AuNP, indicates that accumulation 18 nm AuNP is several-fold higher than the 68 nm AuNP. It is further shown that AuNP response can provide a simple measure for thrombotic risk associated with nano-drugs. From the Clinical Editor Platelet aggregation can be triggered in the presence of gold nanoparticles (AuNP). Platelet response monotonically increases with reduction of the AuNP size. AuNP response can provide a simple measure for thrombotic risk associated with nano-drugs.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21310267</pmid><doi>10.1016/j.nano.2011.01.007</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1549-9634
ispartof Nanomedicine, 2011-08, Vol.7 (4), p.376-384
issn 1549-9634
1549-9642
language eng
recordid cdi_proquest_miscellaneous_888112229
source MEDLINE; Elsevier ScienceDirect Journals
subjects Activation
Adenosine Triphosphate - metabolism
Adhesion
Blood Platelets - drug effects
Blood Platelets - metabolism
Blood Platelets - ultrastructure
Gold - chemistry
Gold nanoparticle
Granule release
Humans
Internal Medicine
Metal Nanoparticles - administration & dosage
Metal Nanoparticles - chemistry
Microscopy, Electron, Scanning
Multi-stability
Nanosafety measure
Phosphorylation - drug effects
Platelet Aggregation - drug effects
Thrombotic risk
Tyrosine - metabolism
title Multistability in platelets and their response to gold nanoparticles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A54%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multistability%20in%20platelets%20and%20their%20response%20to%20gold%20nanoparticles&rft.jtitle=Nanomedicine&rft.au=Deb,%20Suryyani,%20MSc&rft.date=2011-08-01&rft.volume=7&rft.issue=4&rft.spage=376&rft.epage=384&rft.pages=376-384&rft.issn=1549-9634&rft.eissn=1549-9642&rft_id=info:doi/10.1016/j.nano.2011.01.007&rft_dat=%3Cproquest_cross%3E888112229%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=888112229&rft_id=info:pmid/21310267&rft_els_id=S1549963411000116&rfr_iscdi=true